RTA Laboratuvarlari Biyolojik Working Capital to Net Assets Ratio
RTA Laboratuvarlari Biyolojik working capital to net assets ratio. RTA Laboratuvarlari Biyolojik (RTALB) has a Working Capital to Net Assets ratio of 4.5% as of June 2025. Working capital of TL95.63 Million (current assets of TL172.87 Million minus current liabilities of TL77.24 Million) is measured against net assets of TL2.12 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check RTA Laboratuvarlari Biyolojik tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of RTA Laboratuvarlari Biyolojik (2014–2024)
Working capital to net assets ratio of RTA Laboratuvarlari Biyolojik from 2014 to 2024. This chart shows how RTA Laboratuvarlari Biyolojik's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of June 2025, the ratio stands at 4.5%, reflecting working capital of TL95.63 Million against net assets of TL2.12 Billion TRY. See RTA Laboratuvarlari Biyolojik (RTALB) liquidity interval to measure how many days the company can operate on defensive assets alone.
RTA Laboratuvarlari Biyolojik Working Capital to Net Assets Ratio by Year (2014–2024)
RTA Laboratuvarlari Biyolojik working capital to net assets ratio by year from 2014 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for RTA Laboratuvarlari Biyolojik from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of RTA Laboratuvarlari Biyolojik.
| Year | WC/NA Ratio | Working Capital (TRY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -3.6% | TL-60.03 Million | TL1.67 Billion | TL155.04 Million | TL215.07 Million | ▼ -17.9 pp |
| 2023 | 14.3% | TL231.49 Million | TL1.62 Billion | TL359.73 Million | TL128.24 Million | ▼ -19.2 pp |
| 2022 | 33.5% | TL211.95 Million | TL632.74 Million | TL300.53 Million | TL88.59 Million | ▼ -14.4 pp |
| 2021 | 47.9% | TL164.51 Million | TL343.23 Million | TL369.39 Million | TL204.88 Million | ▲ +11.9 pp |
| 2020 | 36.0% | TL60.46 Million | TL167.81 Million | TL142.98 Million | TL82.51 Million | ▲ +5.2 pp |
| 2019 | 30.9% | TL26.75 Million | TL86.69 Million | TL34.56 Million | TL7.81 Million | ▼ -15.1 pp |
| 2018 | 46.0% | TL26.24 Million | TL57.06 Million | TL32.86 Million | TL6.63 Million | ▼ -14.1 pp |
| 2017 | 60.1% | TL32.58 Million | TL54.25 Million | TL40.85 Million | TL8.26 Million | ▲ +4.0 pp |
| 2016 | 56.1% | TL28.16 Million | TL50.20 Million | TL37.44 Million | TL9.28 Million | ▼ -5.6 pp |
| 2015 | 61.7% | TL28.83 Million | TL46.74 Million | TL38.66 Million | TL9.83 Million | ▼ -8.7 pp |
| 2014 | 70.4% | TL26.50 Million | TL37.64 Million | TL36.22 Million | TL9.72 Million | — |